DOCSLIB.ORG

910. Ida Bagus Andhita Male Pseudohermaphroditism 236-.P65

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
910. Ida Bagus Andhita Male Pseudohermaphroditism 236-.P65 Paediatrica Indonesiana VOLUME 46 September - October • 2006 NUMBER 9-10 Case Report Male pseudohermaphroditism due to 5-alpha reductase type-2 deficiency in a 20-month old boy Ida Bagus Andhita, Wayan Bikin Suryawan ntersex conditions are the most fascinating con- paper reports a 20-month old patient with male ditions encountered by clinicians. The ability pseudohermaphroditism due to 5-alpha reductase to diagnose infants born with this disorder has type-2 deficiency. Iadvanced rapidly in recent years. In most cases, clinicians can promptly make an accurate diagnosis and give the advice to the parents on therapeutic Report of the case options. Intersex conditions traditionally have been divided into the following 5 simplified classifications A 20-month old ”girl”, came to the outpatient clinic based on the differentiation of the gonad, i.e. 1) fe- of the Department of Child Health, Sanglah Hospi- male pseudohermaphrodite characterized by two tal, Denpasar, with the chief complaint of a bump on ovaries, 2) male pseudohermaphrodite characterized the urinary duct noted since three months before ad- by two testes, 3) true hermaphrodite characterized mission. The urination and defecation were normal. by ovary and or testis and or ovotestis, 4) mixed go- History of pregnancy and delivery were normal. There nadal dysgenesis characterized by testis plus streak was no history of the same condition among the fam- gonad, and 5) pure gonadal dysgenesis characterized ily. No history of oral contraceptive, alcohol intake, by bilateral streak gonads.1-3 hormonal, or traditional medication during pregnancy. 5-alpha-reductase (5-ARD) type 2 deficiency His growth and development were normal. is an autosomal sex-linked disorder, resulting in Physical examination revealed an alert baby with the inability to convert testosterone to the more regular pulse rate of 120x/minute, respiratory rate of physiological active dihydrotestosterone (DHT). 30x/minute, axillary temperature of 36.5°C. Bodyweight DHT is the most potent androgen, bound selec- tively to the androgen receptors in genital skin and fibroblasts, making its action necessary for the de- velopment of normal male genital anatomy. Since Presented at The 13th National Child Health Congress, Bandung, DHT is required for normal masculinizaton of the Indonesia, July 4-7, 2005. external genitalia in utero, genetic males with 5- From the Department of Child Health, Medical School, Udayana ARD are usually born with ambiguous genitalia University, Denpasar, Bali, Indonesia. (male pseudohermaphroditism).2-4 The hallmark of 5-ARD is elevated ratio of serum testosterone Reprint requests to: Ida Bagus Andhita, MD, Department of Child Health, Medical School, Udayana University, Sanglah Hospital, Jl. P. to DHT. In healthy prepubertal children, the Nias, Denpasar, Bali. Tel. 62-361-227911/15, Ext. 128. Fax. 62-361- baseline testosterone-to-DHT ratio is 1:2.2,4-6 This 244038. 236 • Paediatrica Indonesiana, Vol. 46, No. 9-10 • September - October 2006 Ida Bagus Andhita et al: Male pseudohermaphroditism due to 5-alpha reductase type-2 deficiency was 12 kilograms, body height 85 centimeters, and he 22.0 ng/dl, still within normal values. Before perform- was well nourished. There were no abnormalities of ing hCG test, FSH, LH, testosterone, and DHT lev- head and neck; conjunctiva and sclerae of both eyes els were 11.5 mlU/ml, 0.6 mlU/ml, <2 ng/dl, and <2 were normal, the pupils were isocoric, and reflexes were ng/dl, respectively. After hCG test, testosterone level positive. The chest was symmetrical, the mammae ap- increased to 146 ng/dl while DHT level to 24 ng/dl. propriate to Tanner stage 1, the heart and lungs were Pelvic USG showed an absence of uterus and normal. Abdomen was normal and no mass on palpa- testes were suspected to be localized in right and left tion. Both extremities were normal. inguinal (Figure 2). Genitalia examination revealed the length of The diagnosis was male pseudohermaphrodite phallus was 1.3 cm, there were normal preputium, due to 5-alpha reductase type-2 deficiency. The ventral frenulum, and external urethral orificium. No parents were informed about this disorder, and mass was palpable in labioscrotal area, but a mass with they expected that their child adopts a male gen- a diameter of 1 centimeter was palpable in right in- der identity. guinal (Figure 1). Laboratory results showed WBC of 15,030/μl, haemoglobin of 12.7 g/dl, hematocrit of 40.2%, and Discussion platelets count of 250,000/μl. Urinary examination revealed normal result, renal function test revealed A deficiency of the type-2 isozyme 5-ARD, which normal with BUN of 10.8 mg/dl, and serum creati- transforms testosterone to DHT is the main cause nine of 0.3 mg/dl. Chromosomal analysis revealed 46, of ambiguous genitalia.5,6 Most individuals with XY; and the 17-alpha OHP concentration level was 5-ARD are identified in neonatal periods because FIGURE 1. EXTERNAL GENITAL EXAMINATION SHOWED BILATERAL LABIOSACRAL FOLDS AND SMALL-SIZED PHALUS. Paediatrica Indonesiana, Vol. 46, No. 9-10 • September - October 2006 • 237 Paediatrica Indonesiana FIGURE 2. PELVIC USG SHOWED THE ABSENCE OF UTERUS AND THE LOCATIONS OF BOTH TESTICLES. of ambiguous genitalia. However, some of these that occurs when an infant aged 1-3 months or after children are misdiagnosed as having partial or hCG stimulation.5, 6 complete androgen insensitivity syndrome (AIS), In this case, chromosomal karyotype was 46, which can produce almost identical phenotypes. XY and following hCG stimulation serum test- The clinical abnormalities range from infertility osterone level increased to 146 ng/dl while DHT with normal male genital anatomy to underdevel- was 24 ng/dl. This result showed an elevated ratio oped male with hypospadia to predominantly fe- of serum testosterone to DHT. USG can verify the male external genitalia, most often with mild location of the testes and the absence of the uterus, clitoromegaly. The phallus was indeterminate in which may be present in other conditions.6,7 size with the length falls between 1.0 cm (usual Vaginogram is a useful tool to assess vaginal length maximum for clitoris) and 2.0 cm (lower limit of by introducing small catheter or feeding tube into normal for a penis).5,7-9 the vagina. This study can verify that no fistula The diagnosis of 5-ARD can be confirmed in a connections present between urinary tract and va- patient with 46, XY karyotype. Currently mutation gina.6 In our case, pelvic USG showed the absence analysis of 5-ARD type-2 gene located at band 2p23 of uterus while the testes were suspected to be lo- is available only for research purposes and not com- cated in right inguinal. Based on clinical manifes- mercially. An elevated ratio of serum testosterone to tations, chromosomal karyotype report, hormonal DHT (T/DHT) occurs, demonstrated by the presence serum examination, and pelvic USG, the final di- of high ratio of testosterone serum to DHT. Usually, agnosis was male pseudohermaphrodite due to 5- testosterone level was normal to moderately elevated, alpha reductase type 2 deficiency. The differen- while DHT level is low to undetectable. This level tial diagnosis such as congenital adrenal hyperpla- can be measured at birth during testosterone surge sia, androgen insensitivity syndrome and 17-ke- 238 • Paediatrica Indonesiana, Vol. 46, No. 9-10 • September - October 2006 Ida Bagus Andhita et al: Male pseudohermaphroditism due to 5-alpha reductase type-2 deficiency tosteroid reductase deficiency could be ex- We are of the opinion that the prognosis of fer- cluded.10-15 tility of pseudohermaphroditism due to 5-alpha re- The major issues for individuals with 5-ARD are ductase type-2 deficiency is good. Males with 5 al- gender assignment. Almost all children with 5-ARD pha reductase deficiency have chance to be a fa- are assigned as female at birth. In many cultures which ther, although infertility could happen due to a low early surgery was not performed, some individuals with sperms count. Females with 5-alpha reductase de- 5-ARD adopt male gender identity and male gender ficiency will not be able to be pregnant but they role at puberty.6 still can have a family by either surrogacy or adop- No medical treatment required in infancy and tion. childhood; some evidence suggested that DHT therapy administered prior to puberty may increase penile size.16,17 Providing accurate and complete in- References formation to the child and family with 5-ARD is of paramount importance. Problems about gender and 1. Trijaya B. Kelainan genitalia eksterna. Presented at sexuality can extremely provoke anxiety and emo- Continuing Medical Education IDAI JAYA 2003. tional upset. Multidisciplinary team approach includ- 2. Ambiguous genitalia, conditions and diagnoses. Avail- ing geneticist, pediatric endocrinologist, pediatric psy- able from: URL: http://www.cincinnati_ childrens.org/ chiatrist or pediatric psychologist, pediatric surgeon health/info/urinary/diagnose/genitalia.htm or pediatric urologist is mandatory. 3. Hutchenson J, Snyder HM. Ambiguous genitalia and The geneticist is responsible for verifying the intersexuality. Available from: URL: http://www. karyotype and discussing with the family about this emedicine.com/PED/topic1980.htm abnormality, include the recurrence risk of 1:8 for each 4. Hughes IA. Minireview: Sex differentiation. Endocri- subsequent pregnancy. Pediatric endocrinologist is nology 2001;142(8):3281-7. responsible for verifying the biochemical nature of the 5. Wilson JD, Griffin JE, Russel DW. Steroids 5a-reduc- defect. Pubertal hormone replacement is usually in- tase 2 deficiency. Endocr rev 1993;14:577-93. stituted under supervision of a pediatric endocrinolo- 6. Wilson BE. 5-alpha reductase deficiency. Available gist when the child attains the appropriate age. Pedi- from: URL: http://www.emedicine.com/PED/ atric psychiatrist or pediatric psychologist can help the topic1980.htm family work with psychological issues (e.g.
Load more

Recommended publications
  • Case Report Full Text Online At
    Case Report Full text online at http://www.jiaps.com Penile agenesis A. K. Bangroo, Ramji Khetri, Sashi Tiwari St Stephen's Hospital, Tis Hazari, Delhi Correspondence: AK Bangroo, 103, Administrative block, St. Stephens Hospital, Tis Hazari, Delhi-110054, India. E-mail: [email protected] ABSTRACT Penile agenesis is an extremely rare disorder with profound urological and psychological consequences. The goal of treatment is an early female gender assignment and feminizing reconstruction of the perineum. KEY WORDS: Aphallia, Penile agenesis, Ambiguous genitalia Penile agenesis (PA) is an extremely rare developmental the scrotal folds which were preserved for subsequent anomaly with the reported incidence of 1 in 30 million genital reconstruction. births[1]. PA is believed to result from either the absence of the genital tubercle, or its failure to develop.[2] Several DISCUSSION investigators claim the absence of corpora cavernosa and corpora spongiosum as a prerequisite for the diagnosis of The earliest case report of aphallia was by Imminger in penile agenesis.[3] Except for the reported XX-XY mosaic, 1853[2] since then only 75 cases have been reported in the patients have 46 XY karyotypes.[4] More than half of these literature[6]. Skoog and Belman[5] suggested three variants, have associated anomalies, including developmental de­ based on urethral position in relationship to the anal fects of the caudal axis, genitourinary and gastrointestinal sphincter, as: Postsphincteric; Presphincteric tract anomalies.[5] The scrotum, testes and testicular func­ (Prostatorectal fistula) and Urethral atresia. More proxi­ tion are usually normal[2]. mal the bladder outlet, greater is the likelihood of other anomalies and death.[5] CASE REPORT A two-day-old 3.2 kg genotypic male (46XY) neonate was brought, by a social organization, to our hospital with the complaint of absence of penis, and passage of meco­ nium mixed with urine through rectum.
    [Show full text]
  • A MRI Diagnosis of Congenital Urogenital Anomalies in 27 Years
    Journal of Advances in Radiology and Medical Imaging Volume 4 | Issue 1 ISSN: 2456-5504 Case Report Open Access A MRI Diagnosis of Congenital Urogenital Anomalies in 27 Years Old Man D’Amato D*, Ranalli T, Tatulli D, Bocchinfuso F, Manenti G, Valente F and Bizzaglia M Diagnostic and Interventional Radiology, Policlinico Tor Vergata, University of Rome “Tor Vergata”, Rome, Italy *Corresponding author: D’Amato D, Diagnostic and Interventional Radiology, Policlinico Tor Vergata, University of Rome “Tor Vergata”, Viale Oxford 181, Rome, Italy, Tel: +393207034690, E-mail: [email protected] Citation: D’Amato D, Ranalli T, Tatulli D, Bocchinfuso F, Manenti G, et al. (2019) A MRI Diagnosis of Congenital Urogenital Anomalies in 27 Years Old Man. J Adv Radiol Med Image 4(1): 102 Received Date: April 04, 2019 Accepted Date: August 26, 2019 Published Date: August 28, 2019 Abstract Congenital anorchia is an uncommon clinical condition. Etiology and pathogenetic mechanisms are often unknown. Although some patients with anorchia present with ambiguous external genitalia or micropenis, most have a normal phenotype. XY Disorders of Sex Development classifications are numerous and success rate in establishing a precise diagnosis is far lower than in XX karyotype. We report the case of a young man, with 46 XY karyotype showing various uro-genital abnormalities. A definitive diagnosis was not established due to the complex clinical presentation. Ultrasonography and Magnetic Resonance Imaging techniques were useful tools in the definition of uro-genital anomalies and gonadal development in this complex scenario. Keywords: Anorchia; Cryptorchidism; Urogenital Anomalies; DSD; MRI List of abbreviations: MRI: Magnetic Resonance Imaging; US: Ultrasonography; DSD: Disorders of Sex Development, FSH: Follicle- Stimulating Hormone; HCG: Human Chorionic Gonadotropin; LH: Luteinizing Hormone; AMH Antimüllerian Hormone; LHRH LH- Releasing Hormone; SD: Standard Deviation Introduction The disorders of sexual differentiation constitute a challenging area for both diagnostic and therapeutic impact.
    [Show full text]
  • Growth Hormone Deficiency Causing Micropenis:Peter A
    Growth Hormone Deficiency Causing Micropenis:Peter A. Lee, MD, PhD, a Tom Mazur, PsyD, Lessons b Christopher P. Houk, MD, Learned c Robert M. Blizzard, MD d From a Well-Adjusted Adultabstract This report of a 46, XY patient born with a micropenis consistent with etiology from isolated congenital growth hormone deficiency is used to (1) raise the question regarding what degree testicular testosterone exposure aDepartment of Pediatrics, College of Medicine, Penn State to the central nervous system during fetal life and early infancy has on the University, Hershey, Pennsylvania; bCenter for Psychosexual development of male gender identity, regardless of gender of rearing; (2) Health, Jacobs School of Medicine and Biomedical suggest the obligatory nature of timely full disclosure of medical history; Sciences, University at Buffalo and John R. Oishei Children’s Hospital, Buffalo, New York; cDepartment of (3) emphasize that virtually all 46, XY infants with functional testes and Pediatrics, Medical College of Georgia, Augusta University, a micropenis should be initially boys except some with partial androgen Augusta, Georgia; and dDepartment of Pediatrics, College of Medicine, University of Virginia, Charlottesville, Virginia insensitivity syndrome; and (4) highlight the sustaining value of a positive long-term relationship with a trusted physician (R.M.B.). When this infant Dr Lee reviewed and discussed the extensive medical records with Dr Blizzard, reviewed presented, it was commonly considered inappropriate to gender assign an pertinent medical literature, and wrote each draft infant male whose penis was so small that an adult size was expected to be of the manuscript with input from all coauthors; inadequate, even if the karyotype was 46, XY, and testes were functional.
    [Show full text]
  • DSD Population (Differences of Sex Development) in Barcelona BC N Area of Citizen Rights, Participation and Transparency
    An analysis of the different realities, positions and requirements of the intersex / DSD population (differences of sex development) in Barcelona BC N Area of Citizen Rights, Participation and Transparency An analysis of the different realities, positions and requirements of the intersex / DSD population (differences of sex development) in Barcelona Barcelona, November 2016 This publication forms part of the deployment of the Municipal Plan for Sexual and Gender Diversity and LGTBI Equality Measures 2016 - 2020 Author of the study: Núria Gregori Flor, PhD in Social and Cultural Anthropology Proofreading and Translation: Tau Traduccions SL Graphic design: Kike Vergés We would like to thank all of the respond- ents who were interviewed and shared their knowledge and experiences with us, offering a deeper and more intricate look at the discourses and experiences of the intersex / Differences of Sex Develop- ment community. CONTENTS CHAPTER I 66 An introduction to this preliminary study .............................................................................................................. 7 The occurrence of intersex and different ways to approach it. Imposed and enforced categories .....................................................................................14 Existing definitions and classifications ....................................................................................................................... 14 Who does this study address? ..................................................................................................................................................
    [Show full text]
  • Polycystic Ovary Syndrome
    Review: Polycystic ovary syndrome Polycystic ovary syndrome Maharaj S, MBChB, FCP(SA) Amod A, MBChB, FCP(SA) Department of Endocrinology and Metabolism, Division of Medicine, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, South Africa Correspondence to: Dr Sureka Maharaj, e-mail: [email protected] Keywords: polycystic ovary syndrome, PCOS, polycystic ovarian disease, PCOD, polycystic ovarian morphology, PCOM Introduction The description of polycystic ovaries dates back as far as 17211 but it was Stein and Leventhal who first reported the disorder, that we now know as the polycystic ovary (or ovarian) syndrome (PCOS), in seven women with amenorrhoea, enlarged ovaries with multiple cysts and hirsutism.2 These patients were treated with ovarian wedge resection and of the seven all had return of their menstrual cycles, and two conceived. With the advent of hormonal assays in the late 1960’s and early 1970’s, the diagnostic focus expanded to include endocrine abnormalities in the hypothalamic-pituitary-gonadal (HPG) axis.3 Elevated luteinising hormone (LH) levels and hyperandrogenaemia were therefore added to the diagnostic criteria for PCOS.4 The advent of pelvic ultrasonography in the late 1970’s allowed for the non-invasive detection of polycystic ovarian morphology. However, this tool confounded matters when it was discovered that polycystic ovaries was a “common finding in normal women”,5 and that it also occurred in diverse endocrine disorders such as hypothyroidism, hyperprolactinaemia, congenital adrenal hyperplasia and hypothalamic amenorrhoea.6 The finding of polycystic ovaries in normal women has been variably referred to as polycystic ovarian disease (PCOD), polycystic ovaries (PCO) and polycystic ovarian morphology (PCOM).
    [Show full text]
  • Micropenis Associated with Testicular Agenesis
    Arch Dis Child: first published as 10.1136/adc.50.3.247 on 1 March 1975. Downloaded from Short reports 247 REFERENCES Patients Barnes, N. D., Joseph, J. M., Atherden, S. M. and Clayton, B. E. (1972). Functional tests of adrenal axis in children with Case 1. The second child of unrelated parents, born measurement of plasma cortisol by competitive protein binding. after a normal term pregnancy. At birth it was difficult Archives of Disease in Childhood, 47, 66. to decide the infant's sex. A minute penis consisting of Deane, H. W., and Masson, G. M. C. (1951). Adrenal cortical a small prepuce-like skin tag devoid of palpable erectile changes in rats with various types of experimental hypertension. .ournal of Clinical Endocrinology, 11, 193. tissue was present (Fig. 1). The urethral orifice could Fanconi, G. (1954). Tubular insufficiency and renal dwarfism. not be seen but urine was passed from this area. Testes Archives of Disease in Childhood, 29, 1. could not be felt in the small, fleshy scrotum. Physical Howse, P. M., Rayner, P. H. W., Williams, J. W., and Rudd, B. T. (1974). Growth hormone secretion during sleep in short examination was otherwise normal. children: a continuous sampling study. Archives of Disease in Childhood, 49, 246. James, V. H. T., Townsend, J., and Fraser, R. (1967). Comparison of fluorimetric and isotopic procedures for the determination of plasma cortisol. journal of Endocrinology, 37, xxviii. Mattingly, D. (1962). A simple fluorimetric method for the estimation of free 1 1-hydroxycorticoids in human plasma. Journal of Clinical Pathology, 15, 374.
    [Show full text]
  • Anne Tamar-Mattis, JD* Advocates for Informed Choice
    Report to the Inter-American Commission on Human Rights: Medical Treatment of People with Intersex Conditions as a Human Rights Violation Anne Tamar-Mattis, JD* Advocates for Informed Choice March 13, 2013 I. Introduction Americans born with intersex conditions, or variations of sex anatomy, face a wide range of violations to their sexual and reproductive rights, as well as the rights to bodily integrity and individual autonomy. Beginning in infancy and continuing throughout childhood, children with intersex conditions are subject to irreversible sex assignment and involuntary genital normalizing surgery, sterilization, medical display and photography of the genitals, and medical experimentation. In adulthood, and sometimes in childhood, people with intersex conditions may also be denied necessary medical treatment. Moreover, intersex individuals suffer life-long physical and emotional injury as a result of such treatment. These human rights violations often involve tremendous physical and psychological pain and arguably rise to the level of torture or cruel, inhuman, or degrading treatment (CIDT).† The treatment experienced by American intersex people is a violation of the American Convention on Human Rights. The Convention recognizes torture and cruel, inhuman, or degrading treatment (CIDT) as human rights abuses. Under Article V, “(1) Every person has the right to have his physical, mental, and moral integrity respected. (2) No one shall be subjected to torture or to cruel, inhuman, or degrading punishment or treatment.” §1-2. In order to demonstrate why specific medical practices are human rights abuses against intersex people, we have applied Article 16 of the Convention Against Torture (CAT), and interpretations by the European Court of Human Rights and the mandate of the Special Rapporteur on Torture (SRT).
    [Show full text]
  • Disorders of Sexual Differentiation and Surgical Corrections
    Marmara Medical Journal Volume 2 No: 5 April 1989 DISORDERS OF SEXUAL DIFFERENTIATION AND SURGICAL CORRECTIONS C. Ôzsoy, M.D.* / A. KadioÇlu, M.D.*** / H. Ander, M.D.** * Professor, Department of Urology, Istanbul Medical Faculty, Istanbul, Turkey. ** Associate Professor, Department of Urology, Istanbul Medical Faculty, Istanbul, Turkey. * * * Research Assistant, Department of Urology, Istanbul Medical Faculty, Istanbul, Turkey. SUMMARY Patients with ambiguous genitalia who applied to our ?). Developments in Cytogenetics and Radio-immu- clinic are investigated and they are classified as true no assay after 1950's provided the easy diagnosis of hermaphroditism, male and female pseudohermaph­ sexual differentiation disorders. roditism. Normal sexual differentiation: The normal human After chromosomal, psychological, hormonal, phe­ diploid cell contains 22 autosomal pairs of chromoso­ notypic and surgical evaluation, the final sex is de­ mes and 2 sex chromosomes. Except spermatozoon termined and appropriate reconstructive surgery is and oocyt normal human cell is diploid. The chromo­ performed. somal sex is determined at the time of fertilization. An XX female or male determined chromosomal sex, In six of our 18 patients we reassigned the female sex influences sexual differentiation by causing the bipo- to male. 2 of our 18 patients are true hermaphrodites tenlial gonad to develop either as a testis or as an (one being male and the other is female). 2 of them are ovary. female pseudohermaphrodites and 14 of them are male pseudohermaphrodites. 6 patients who under­ Until the 7th week of gestation the gonads are indis­ went sexual reassignment were male pseudoher- tinguishable. In the presence of Y chromosome or H- maphrodiles. Y antigen, which is located on the short arm of X chromosome, the medulla of gonads will begin testi­ In our opinion the most important aspect of sex reas­ cular differentiation.
    [Show full text]
  • Pathogenic Variants in the DEAH-Box RNA Helicase DHX37 Are a Frequent Cause of 46,XY Gonadal Dysgenesis and 46,XY Testicular Regression Syndrome
    ARTICLE © American College of Medical Genetics and Genomics Pathogenic variants in the DEAH-box RNA helicase DHX37 are a frequent cause of 46,XY gonadal dysgenesis and 46,XY testicular regression syndrome Ken McElreavey, PhD 1, Anne Jorgensen, PhD 2, Caroline Eozenou, PhD1, Tiphanie Merel, MSc1, Joelle Bignon-Topalovic, BSc1, Daisylyn Senna Tan, BSc3, Denis Houzelstein, PhD 1, Federica Buonocore, PhD 4, Nick Warr, PhD 5, Raissa G. G. Kay, PhD5, Matthieu Peycelon, MD, PhD 6,7,8, Jean-Pierre Siffroi, MD, PhD6, Inas Mazen, MD9, John C. Achermann, MD, PhD 4, Yuliya Shcherbak, MD10, Juliane Leger, MD, PhD11, Agnes Sallai, MD 12, Jean-Claude Carel, MD, PhD 11, Laetitia Martinerie, MD, PhD11, Romain Le Ru, MD13, Gerard S. Conway, MD, PhD14, Brigitte Mignot, MD15, Lionel Van Maldergem, MD, PhD 16, Rita Bertalan, MD, PhD17, Evgenia Globa, MD, PhD 18, Raja Brauner, MD, PhD19, Ralf Jauch, PhD 3, Serge Nef, PhD 20, Andy Greenfield, PhD5 and Anu Bashamboo, PhD1 Purpose: XY individuals with disorders/differences of sex devel- specifically associated with gonadal dysgenesis and TRS. opment (DSD) are characterized by reduced androgenization Consistent with a role in early testis development, DHX37 is caused, in some children, by gonadal dysgenesis or testis regression expressed specifically in somatic cells of the developing human during fetal development. The genetic etiology for most patients and mouse testis. with 46,XY gonadal dysgenesis and for all patients with testicular Conclusion: DHX37 pathogenic variants are a new cause of an regression syndrome (TRS) is unknown. autosomal dominant form of 46,XY DSD, including gonadal Methods: We performed exome and/or Sanger sequencing in 145 dysgenesis and TRS, showing that these conditions are part of a individuals with 46,XY DSD of unknown etiology including clinical spectrum.
    [Show full text]
  • 46 XY Gonadal Dysgenesis in Adulthood 'Pitfalls of Late Diagnosis'
    BMJ Case Reports: first published as 10.1136/bcr.12.2010.3626 on 10 February 2012. Downloaded from Reminder of important clinical lesson 46 XY gonadal dysgenesis in adulthood ‘pitfalls of late diagnosis’ Jarna Naing Hamin, 1 Francis Raymond P Arkoncel,2 Frances Lina Lantion-Ang, 1 1 Mark Anthony S Sandoval 1 Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, Philippine General Hospital, University of the Philippines Manila, Manila, Philippines ; 2 Division of Urology, Department of Surgery, Philippine General Hospital, University of the Philippines Manila, Manila, Philippines Correspondence to Dr Mark Anthony S Sandoval, [email protected] Summary Disorders of sex development (DSD) include congenital conditions where developments of chromosomal, gonadal or anatomical sex are atypical. Ostrer in 2000, reported a prevalence of 1:20 000 for 46 XY DSD and complete gonadal dysgenesis. A 21-year-old patient consulted for sexual ambiguity at the out-patient department of the Philippine general hospital. At birth, the perceived female external genitalia and clitoromegaly, led the parents to register and eventually rear the patient as a female. At puberty, he developed masculine features and growth of phallus. Patient was more interested in male activities and began to identify himself as male in the community. The discrepancy between his birth certifi cate and his male gender jeopardised his ambition to become a policeman; this led him to seek medical consult. On physical examination, he was phenotypically male. The external genitalia showed the phallus length of 3.5 cm and perineoscrotal hypospadias. Chromosomal sex was normal 46 XY with neither numerical nor structural aberrations in all cell lines, serum testosterone was low and gonadotrophins were elevated.
    [Show full text]
  • 5-Α Reductase Deficiency in Two Siblings: a Case Report
    Elmer ress Case Report J Med Cases. 2016;7(7):263-265 5-α Reductase Deficiency in Two Siblings: A Case Report Ivana Capina, c, Mary Ryanb Abstract genitalia and undervirilization [4]. Androgen receptors must be present and responsive to DHT and testosterone in order for A deficiency of 5-α reductase is a rare genetic disorder that affects external sexual characteristics to take effect. A defect in any of 46,XY patients. The lack of enzyme causes inadequate differen- the previously mentioned enzymes or hormone receptors could tiation of the gonads, leading to ambiguous genitalia or complete lead to discordance between genotype and phenotype [5]. feminization of the external genitalia. Two sisters presented to their Androgen insensitivity is the most common disorder endocrinologist complaining of primary amenorrhea. Molecular stud- of sexual development with an incidence of 2:100,000 to ies revealed the SRD5A2 His231Arg gene mutation and karyotype 5:100,000 [6]. It is an X-linked recessive disorder in which showed 46,XY genotype. The diagnosis was supported by their high there are mutations coding for the androgen receptor leading to testosterone/dihydrotestosterone (DHT) ratio, response to the hCG partial androgen insensitivity, complete androgen insensitivity stimulation test and their elevated sex hormone binding globulin or mild androgen insensitivity [5]. Partial androgen insensitiv- (SHBG) levels. The siblings continued to identify as the female gen- ity syndrome (PAIS) is just as common as complete androgen der and were placed on oral premarin to develop secondary female insensitivity syndrome (CAIS), if not more [6]. Since it is the sexual characteristics.
    [Show full text]
  • EAU-Guidelines-On-Paediatric-Urology-2019.Pdf
    EAU Guidelines on Paediatric Urology C. Radmayr (Chair), G. Bogaert, H.S. Dogan, R. Kocvara˘ , J.M. Nijman (Vice-chair), R. Stein, S. Tekgül Guidelines Associates: L.A. ‘t Hoen, J. Quaedackers, M.S. Silay, S. Undre European Society for Paediatric Urology © European Association of Urology 2019 TABLE OF CONTENTS PAGE 1. INTRODUCTION 8 1.1 Aim 8 1.2 Panel composition 8 1.3 Available publications 8 1.4 Publication history 8 1.5 Summary of changes 8 1.5.1 New and changed recommendations 9 2. METHODS 9 2.1 Introduction 9 2.2 Peer review 9 2.3 Future goals 9 3. THE GUIDELINE 10 3.1 Phimosis 10 3.1.1 Epidemiology, aetiology and pathophysiology 10 3.1.2 Classification systems 10 3.1.3 Diagnostic evaluation 10 3.1.4 Management 10 3.1.5 Follow-up 11 3.1.6 Summary of evidence and recommendations for the management of phimosis 11 3.2 Management of undescended testes 11 3.2.1 Background 11 3.2.2 Classification 11 3.2.2.1 Palpable testes 12 3.2.2.2 Non-palpable testes 12 3.2.3 Diagnostic evaluation 13 3.2.3.1 History 13 3.2.3.2 Physical examination 13 3.2.3.3 Imaging studies 13 3.2.4 Management 13 3.2.4.1 Medical therapy 13 3.2.4.1.1 Medical therapy for testicular descent 13 3.2.4.1.2 Medical therapy for fertility potential 14 3.2.4.2 Surgical therapy 14 3.2.4.2.1 Palpable testes 14 3.2.4.2.1.1 Inguinal orchidopexy 14 3.2.4.2.1.2 Scrotal orchidopexy 15 3.2.4.2.2 Non-palpable testes 15 3.2.4.2.3 Complications of surgical therapy 15 3.2.4.2.4 Surgical therapy for undescended testes after puberty 15 3.2.5 Undescended testes and fertility 16 3.2.6 Undescended
    [Show full text]